The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - JW Pharmaceutical
Stock and Other Ownership Interests - JW Pharmaceutical
Consulting or Advisory Role - Quanticel Pharma
Research Funding - JW Pharmaceutical (Inst)
Other Relationship - JW Pharmaceutical
 
Research Funding - JW Pharmaceutical (Inst)

Phase 1 study of CWP232291 in relapsed/refractory acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS).
 
Jorge E. Cortes
Research Funding - JW Pharmaceutical (Inst); PRISM Pharma (Inst)
 
Stefan Faderl
Research Funding - JW Pharmaceutical (Inst)
 
John Pagel
Research Funding - JW Pharmaceutical (Inst)
 
Chul Won Jung
Research Funding - JW Pharmaceutical (Inst)
 
Sung-Soo Yoon
Research Funding - JW Pharmaceutical (Inst)
 
Youngil Koh
No Relationships to Disclose
 
Animesh Dev Pardanani
Research Funding - JW Pharmaceutical (Inst)
 
Robert S Hauptschein
No Relationships to Disclose
 
Kyoung-June Lee
Employment - JW Pharmaceutical
 
Je-Hwan Lee
Research Funding - JW Pharmaceutical (Inst)